The efficacy of long‐term maintenance therapy with a levonorgestrel‐releasing intrauterine system for prevention of ovarian endometrioma recurrence

Mi‐La Kim, Mi-La Kim, Yeon Jean Cho, Mi Kyoung Kim, Yong Wook Jung, Bo Seong Yun, Seok Ju Seong
International Journal of Gynecology & Obstetrics · 2016 · vol. 134(3) , pp. 256–259 · doi:10.1016/j.ijgo.2016.03.017 · PMID:27346551 · W2416074282
article OA: closed CC0 ⤵ 12 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study found that long-term levonorgestrel-releasing intrauterine system maintenance therapy after conservative surgery was associated with recurrence rates of 4.0% at 24 months and 6.3% at 36 months in premenopausal women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To evaluate the cumulative recurrence rates of ovarian endometrioma among patients using a levonorgestrel-releasing intrauterine system (LNG-IUS) after conservative laparoscopic surgery. METHODS: A retrospective review was conducted of premenopausal women who underwent conservative laparoscopic surgery for ovarian endometrioma and subsequent treatment with LNG-IUS at two gynecologic surgery centers in South Korea between January 1, 2007, and September 30, 2014. Eligible patients had no residual ovarian lesions before LNG-IUS insertion, underwent insertion within 12 months of primary surgery, and were followed up for at least 6 months afterwards. Recurrence was defined as a cystic mass (≥2 cm in diameter) detected by transvaginal ultrasonography. RESULTS: Overall, 61 patients were included. The mean duration of follow-up was 42.9 ± 22.0 months (range 8-98). Recurrence of ovarian endometrioma was detected among 7 (11%) of the patients. On Kaplan-Meier analysis, the cumulative recurrence rates were 4.0%, 6.3%, and 25.5% at 24, 36, and 60 months after surgery, respectively. In multivariate analysis, nulliparity at surgery was the only risk factor for recurrence (hazard ratio 5.892, 95% confidence interval 1.139-30.484; P=0.034). CONCLUSION: Long-term maintenance therapy with LNG-IUS after conservative surgery might be a treatment option to consider to prevent ovarian endometrioma recurrence among premenopausal women.

My notes (saved in your browser only)

Condition tags

endometriosisendometrioma

MeSH descriptors

Contraceptives, Oral, Combined Endometriosis Levonorgestrel Neoplasm Recurrence, Local Ovarian Neoplasms Adult Combined Modality Therapy Contraceptives, Oral, Combined Drug Administration Schedule Endometriosis Endometriosis Female Humans Levonorgestrel Middle Aged Neoplasm Recurrence, Local Neoplasm Recurrence, Local Ovarian Neoplasms Ovarian Neoplasms Republic of Korea

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (28)

Cited by (12)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:21:00.404924+00:00
License: CC0 · commercial use OK